Table 1 Baseline characteristics of the experimental dataset
From: Utilizing dynamic treatment information for MACE prediction of acute coronary syndrome
Characteristics | No. of participants (n = 2930) |
|---|---|
Demographics | |
 Age, (mean ± sdv.) [min-max] | 62.27 ± 12.11 [28–91] |
 Gender, Male/Female | 2079/851 |
Physical examination, (mean ± sdv.) [min-max] | |
 Systolic BP, mm Hg | 132.10 ± 17.64 [11–240] |
 Diastolic BP, mm Hg | 77.59 ± 10.17 [35–120] |
 Height, cm | 167.01 ± 8.15 [56–188] |
 Weight, kg | 71.81 ± 12.42 [32–200] |
 Ejection Fraction, (mean ± sdv.) [min-max] | 59.51 ± 7.82 [17–78] |
Comorbid conditions (%) | |
 Diabetes | 803 (27.4%) |
 Hypertension | 1981 (67.6%) |
 Heart Failure | 165 (5.6%) |
 arteriosclerosis | 2267 (77.4%) |
 History of current or previous smoking | 1113 (38.0%) |
Laboratory data, (mean ± sdv.) [min-max] | |
 Creatinine, umol/L | 78.72 ± 38.18 [29.5–739.4] |
 Creatinine kinase, umol/L | 86.11 ± 112.02 [6.2–4651.1] |
 Alanine aminotransferase, umol/L | 26.02 ± 27.66 [1.7–593] |
 Aspartate aminotransferase, umol/L | 21.70 ± 19.53 [5.8–589.4] |
 Troponin T, ng/ml | 0.029 ± 0.084 [0.002–0.886] |
 Glucose, umol/L | 6.16 ± 2.26 [2.69–28.62] |
Disease/Treatment history (%) | |
 Post-PCI (patient who has taken PCI surgery in the past and was admitted into the hospital at this time) | 816 (27.8%) |
 Post-CABG (patient who has taken CABG surgery in the past and was admitted into the hospital at this time) | 46 (1.6%) |
Length of Stay, (mean ± sdv.) [min-max] | 9.12 ± 7.05 [1–54] |
MACE (%) | 752 (22.4%) |